Activation patterns of murine B cells after oral administration of an encapsulated soluble antigen

Vaccine

Volumn 14, Issue 1, 1996, Pages 42-48

  Jain, Shilpa L ^a   Barone, K Siobhan ^a   Flanagan, Michael P ^a   Michael, J Gabriel ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Biodegradable polymer; Mucosal immunity; Oral administration of antigens; Ovalbumin

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G1; OVALBUMIN; POLYACRYLIC ACID;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PEYER PATCH; PRIORITY JOURNAL;

EID: 0343026537     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00158-W     Document Type: Article

References (37)

1. O'Hagan, D.T. Oral immunization and the common mucosal immune system. In: Novel Delivery Systems for Oral Vaccines (Ed. O'Hagan, D.T.). CRC Press, Inc., Boca Raton, FL, 1994, pp. 1-24
2. Craig, S.W. and Cebra, J.J. Payer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J. Exp. Med. 1971, 134, 188-200
3. Lamm, M.E. Cellular aspects of Immunoglobulin A. Adv. Immunol. 1976, 22, 223-290
4. Mestecky, J., Abraham, R. and Ogra, P.L. Common mucosal immune system and strategies for the development of vaccines effective at the mucosal surfaces. In: Handbook of Mucosal Immunology (Eds Ogra, P.L., Mestecky, J., Lamm, M.E., Strober, W., McGhee, J.R. and Bienenstock, J.). Academic Press, Inc., San Diego, CA, 1994, pp. 357-372
5. Mowat, A. The regulation of immune responses to dietary protein antigens, Immunol. Today 1987, 8, 93-98
6. Higgins, P.J. and Weiner, H.L. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 1988, 140, 440
7. Kagnoff, M.F. Oral tolerance. Monogr. Allergy 1988, 24, 222-226
8. Mestecky, J. and McGhee, J.R. Oral immunization-past and present. Curr. Top. Microbiol. Immunol. 1989, 146, 3-11
9. McGhee, J.R., Mestecky, J., Dertzraugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10, 75-88
10. Michael, J.G. The role of digestive enzymes in orally induced immune tolerance, Immunol. Invest. 1989, 18, 1049-1054
11. Jain, S.L. and Michael, J.G. Influence of gastric digestion on orally induced tolerance and immunity. In: Recent Advances in Mucosal Immunology (Eds McGhee, J.R., Mestecky, J., Tlsakalova, H. and Sterzl, J.). Plenum Publishing Co., New York, NY, 1995, 1245-1250
12. Flanagan, M.F., Wang, C. and Michael, J.G. Characterization of the immune response following the oral administration of modified antigen in an adjuvant-free system. J. Immunol. 1993, 150, 35A
13. Michael, J.G., Flanagan, M.P. and Jain, S.L. Oral administration of encapsulated allergen. In: International Association of Allergology and Clinical Immunology XV European Academy of Allergology and Clinical Immunology '94, Stockholm, Sweden, 1994
14. Ferguson, T.A., Peters, T., Reed, R., Pesce, A.J. and Michael, J.G. Immunoregulatory properties of antigenic fragments of bovine serum albumin. Cell. Immunol. 1983, 78, 1-12
15. Taguchi, T., McGhee, J.R., Coffman, R.L. et al. Analysis of Th1 and Th2 cells in the murine gut-associated tissues. J. Immunol. 1990, 145, 68-77
16. Moller, S.A. and Borrebaeck, C.A.K. A filter immuno-plaque assay for the detection of antibody secreting cells in vitro. J. Immunol. Meth. 1985, 79, 195-204
17. McGhee, J.R. and Kiyono, H. Mucosal immunity to vaccines: Current concepts for vaccine development and immune response analysis. Adv. Exp. Med. Biol. 1992, 327, 3-12
18. McGhee, J. and Mestecky, J. Mucosal vaccines: areas arising. Mucosal Immunol. Update 1993, 1, 1-15
19. Lycke, N. and Holmgren, J. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presente antigens. Immunology 1986, 59, 301-308
20. Michalek, S.M., Childers, N.K., Katz, J. et al. Liposomes as oral adjuvants. Curr. Top, Microbiol. Immunol. 1989, 146, 51
21. Ogra, P., Leibovitz, E. and Rg, Z. Oral immunization and secretory immunity to viruses. Curr. Top. Microbiol. Immunol. 1989, 146, 73-81
22. Eldridge, J.H., Staas, J.K., Meulbroek, J.A., McGhee, J.R., Tice, T.E. and Gilley, R.M. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target for Peyer's patches. J. Controll. Rel. 1991, 11, 205-214
23. O'Hagan, D.T. Oral delivery of vaccines - formulation and clinical pharmacokinetic considerations. Clin. Pharm. 1992, 22, 1-10
24. O'Hagan, D.T. Microparticles as oral vaccines. In: Novel Delivery Systems for Oral Vaccines (Eds O'Hagan, D.T.). CRC Press, Inc., Boca Raton, FL, 1994, pp. 175-205
25. Miller, R.A., Brady, J.M. and Cutright, D.W. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios. J. Biomed. Mater. Res. 1977, 11, 711
26. Mestecky, J. and Eldridge, J.H. Targeting and controlled release of antigens for the effective induction of secretory antibody responses. Curr. Opin. Immunol. 1991, 3, 492-495
27. O'Hagan, D.T., McGee, J.P., Holmgren, J. et al. Biodegradable microparticles for oral immunization. Vaccine 1993, 11, 149-154
28. Walker, R.L. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994, 12, 387-400
29. Jain, S.L. and Michael, J.G. B cell and T cell activation patterns after oral administration of encapsulated soluble antigen. FASEB J. 1994, 8, A516
30. Flanagan, M., Jain, S. and Michael, J. Breaking of oral tolerance by an encapsulated antigen. Ann. NY Acad. Sci. 1995, 778, 373-375
31. McDermott, M.R. and Bienenstock, J. Evidence for a common mucosal immunologic system: I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immunol. 1979, 122, 1892-1898
32. Mestecky, J. The common mucosal immune system and current stratagies for induction of immune resonses in external secretions. J. Clin. Immunol. 1987, 7, 265-276
33. Mosmann, T.R. and Coffman, R.L. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7, 145-173
34. Mowat, A.M., Donachie, A.M., Reid, G. and Jarrett, O. Immune stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route. Immunology 1991, 72, 317-322
35. Xu-Amano, J., Aicher, W.K., Taguchi, T, Kiyono, H. and McGhee, J.R. Selective induction of Th2 cells in murine Peyer's patches by oral immunization. Int. Immunol. 1992, 4, 433-445
36. Xu-Amano, J., Kiyono, H., Jackson, R.J. et al. Helper T cell subsets for Immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 1993, 178, 1309-1320
37. Litwin, A., Flanagan, M.F., Entis, G., Gottschlich, G. and Michael, J.G. Orally administered short ragweed extract in the treatment of ragweed hayfever: a phase I study. J. Immunol. 1993, 150, 63A